Skip to main content
Journal ArticleOPEN ACCESS

Anti-angiogenic therapy for lung cancer

  • Pavlakis N
  • Marx G
  • White S
  • et al.
Cochrane Database of Systematic Reviews (2009)
DOI: 10.1002/14651858.cd008047
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo‐radiotherapy (in the case of locally advanced non‐metastatic NSCLC or limited stage SCLC).

Cite

CITATION STYLE

APA

Pavlakis, N., Marx, G., White, S., Lee, C. W., & Khasraw, M. (2009). Anti-angiogenic therapy for lung cancer. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free